Literature DB >> 21099599

Common abnormal results of pap and human papillomavirus cotesting: what physicians are recommending for management.

Zahava Berkowitz1, Mona Saraiya, Vicki Benard, K Robin Yabroff.   

Abstract

OBJECTIVE: To evaluate the association between physician and practice characteristics and adherence to management guidelines to better understand the factors associated with different screening recommendations by primary care physicians.
METHODS: We used a cross-sectional nationally representative survey of 950 primary care physicians familiar with human papillomavirus (HPV) testing to assess adherence to management guidelines by analyzing responses to two clinical vignettes of a 35-year-old woman who had Pap and HPV tests results: 1) discordant (normal Pap and positive HPV) or 2) mildly abnormal (atypical squamous cells of undetermined significance Pap and negative HPV). Analyses included multivariable logistic regression.
RESULTS: For the discordant test results, 54.3% (95% confidence interval [CI] 51-57.6%) of physicians recommended both Pap and HPV testing in 6-12 months, adhering to management guidelines. For the mildly abnormal results, only 12.2% (95% CI 10-14.7%) had a guideline-adherent recommendation of Pap testing in 12 months with no HPV test. In multivariable analyses, no significant difference among physicians' specialties was observed for the discordant results. For the mildly abnormal results, physician specialty was associated with guideline adherence in which obstetrician-gynecologists had the highest percent of adherence (19.8%) compared with family and general practitioners (9.3%) and internists (11%) (P<.001).
CONCLUSION: Even for the most common abnormal results, many physicians reported recommendations that did not adhere to current management guidelines. Evidence-based interventions are needed to improve adherence to management guidelines for the newer HPV DNA test.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21099599     DOI: 10.1097/AOG.0b013e3181fae4ca

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Opting out of cervical cancer screening: physicians who do not perform pap tests.

Authors:  Crystale Purvis Cooper; Mona Saraiya
Journal:  Am J Prev Med       Date:  2014-06-18       Impact factor: 5.043

2.  Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.

Authors:  Michelle I Silver; Anne F Rositch; Darcy F Phelan-Emrick; Patti E Gravitt
Journal:  Cancer Causes Control       Date:  2017-11-09       Impact factor: 2.506

3.  Cancer screening practices among physicians in the national breast and cervical cancer early detection program.

Authors:  Vicki B Benard; Mona S Saraiya; Ashwini Soman; Katherine B Roland; K Robin Yabroff; Jackie Miller
Journal:  J Womens Health (Larchmt)       Date:  2011-07-20       Impact factor: 2.681

4.  Impact of an educational tool on young women's knowledge of cervical cancer screening recommendations.

Authors:  Heike Thiel de Bocanegra; Christine Dehlendorf; Miriam Kuppermann; Sitaram S Vangala; Anna-Barbara Moscicki
Journal:  Cancer Causes Control       Date:  2022-03-21       Impact factor: 2.532

5.  Formative evaluation of the accuracy of a clinical decision support system for cervical cancer screening.

Authors:  Kavishwar Balwant Wagholikar; Kathy L MacLaughlin; Thomas M Kastner; Petra M Casey; Michael Henry; Robert A Greenes; Hongfang Liu; Rajeev Chaudhry
Journal:  J Am Med Inform Assoc       Date:  2013-04-05       Impact factor: 4.497

6.  Assessing Physician Adherence to Guidelines for Cervical Cancer Screening and Management of Abnormal Screening Results.

Authors:  Caroline J Min; L Stewart Massad; Rebecca Dick; Matthew A Powell; Lindsay M Kuroki
Journal:  J Low Genit Tract Dis       Date:  2020-10       Impact factor: 3.842

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.